TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of postoperative falls
Endpoint domain: Adverse events/effects
Primary endpoint: ADL functions of the upper extremity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Immunogenicity index-seroconversion rate of type I anti-poliovirus neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunogenicity index-seroconversion rate of type II anti-poliovirus neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunogenicity index-seroconversion rate of type III anti-poliovirus neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunogenicity index-seropositive rate of type I anti-poliovirus neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence rate of severe hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: A1c at 3, 6, 9 and 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of participants achieving A1C < 7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: proportion of patients who do not restart hormonal therapy within 1 year
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recruitment and attrition rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of sessions attended
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Short Physical Performance Battery (SPPB) composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Falls Efficacy Scale (FES) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sarcopenia Quality of Life (SarQoL) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Occurrence and incidence of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Bacterial colonization in bile and gallbladder wall samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Antibiotic resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Histopathology of the gallbladder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBPM systolic blood pressure (SBP) area under the curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VAS Pain Severity Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Subjects Without a Clinically Significant Increase in RLS Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in level of Fluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extreme Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Brain Fog
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Clinical and radiological performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients with BMI greater than 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: BOLD fMRI response to acute stress task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binding potential of [18F]-DPA-714 radiotracer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate after Fundoplicature
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: lung recruitment rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Muscle selectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscle functional selectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: effective placement of the device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Modified Barthel Index scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: EEG (Electroencephalogram)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Executive Function Task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Biochemical marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score using Numerical rating Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline depression score to after treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline anxiety score to after treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HDL cholesterol efflux capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acceptability of the breathwork session
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of the breathing session
Endpoint domain: Adverse events/effects
Primary endpoint: Scale of attitudes of students towards patients with chronic pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Chronic pain management knowledge test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic pain management training program evaluation
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Optometric result (2WIN-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with hair loss score ≤ 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: patient movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma and urine levels of blueberry derived polyphenols and their metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anthropometric Characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinal Posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ribociclib Area-under-the-curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SARS-Cov2 viral load in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Perceived Level of Stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confusion Assessment Method for the ICU (CAM-ICU) assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electroencephalogram (EEG) Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of motor function of face
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of intact sensation of face
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of an ascetically satisfactory appearing face
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of a cost benefit to facial transplant
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Laboratory values (haematology)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: change from baseline in mean diurnal IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Loco-regional and Distant Tumor Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximal voluntary isometric contraction of the transversus abdominis muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximal voluntary isometric contraction of the lumbar multifidus muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: change in anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Cerebral Palsy Quality of Life Questionnaire (CPQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Child and Adolescent Scale of Participation (CASP)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: DASH diet score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute headache medications usage days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Difference in intraocular structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Difference in intraocular vascular structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Anticipatory Center of Mass Excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blind-assessed tumor size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Blind-assessed deep and lateral margin measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in end tidal carbon dioxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Walking after the operation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of patients considering siderails as a physical restraint method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of health professionals considering siderails as a physical restraint method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Amount of skeletal expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants who Experience at Least One Adverse Drug Reactions (ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in physical activity over time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Exercise over time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement on the Perioral Lines Severity Scale (POLSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of episodes of pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Manifest Cylinder (MRCYL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance 1 (Number of days out of 30 the patients used the device)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Efficiancy 2 (Effect size for change of depressivity for patients in the per protocol analysis measured with the Hamilton depression rating scale (21 items))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stability of effects 2 (Effect size for change of depressivity for patients in the per protocol analysis measured with the Hamilton depression rating scale (21 items))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality of premature infants
Endpoint domain: Mortality/survival
Primary endpoint: Severe complications of premature infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrical activity in the basal ganglia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Continuity of patients' treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Dyslipidemia levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients completing therapy without severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of MCG data meeting quality requirements
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Revised Childrens Anxiety and Depression Scale-Parent Version
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants with extubation failure
Endpoint domain: Adverse events/effects
Primary endpoint: Cause of reintubation
Endpoint domain: Adverse events/effects
Primary endpoint: Number and severity of drug-related treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: response to PRF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention adherence rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gram-negative bacterial resistance emergence
Endpoint domain: Adverse events/effects
Primary endpoint: fine finger movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients with at least one toxicity requiring intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline 24-hour mean ambulatory SBP at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline daytime mean ambulatory SBP at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Control rate of hypertension at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change bacterial colony count in wound bed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change white blood cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change high sensitivity C-reactive protein (hsCRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-weighted sum of Pain Intensity Difference (SPID) as Recorded on a Numeric Pain Rating Scale (NPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Neuropathy Impairment Score-lower Limb (NIS-LL) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Grasp Release Test (GRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with abnormal microanatomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thickness of the participants retina at the fovea and surrounding optic nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended Phase 2 Dose (PR2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-emergent adverse events (TEAEs) leading to withdrawal of study medication
Endpoint domain: Adverse events/effects
Primary endpoint: Number of risk factors associated with postoperative morbidity
Endpoint domain: Mortality/survival
Primary endpoint: Number of risk factors associated with postoperative mortality
Endpoint domain: Mortality/survival
Primary endpoint: Average Daily Opioid Consumption in MME
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation in the Visual Analog Scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Difference in postprandial digestive well-being
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Difference in postprandial fullness sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in postprandial mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients who experience ischemic stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients who experience Acute Kidney Injury (AKI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of patients who experience death
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients who experience delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic Organ Prolapse / Incontinence Sexual Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Visual Analogue Scale of perceived stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concentration of plasma cathecolamines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean change in tear inflammatory cytokine milieu
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in GRBAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repeat TEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repeat Head CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total fentanyl dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Flexion Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Knee Extension Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Kujala Score (AKPS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of patients with abnormal left atrial strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Identification of a GAG layer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Safety primary endpoint
Endpoint domain: Adverse events/effects
Primary endpoint: Patient perception of decision process and quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in the isoform levels of MBNL1 and MBNL2 in corneal endothelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: localisation of foci and rotors maintaining NOAF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of proven, probable and possible IA
Endpoint domain: Adverse events/effects
Primary endpoint: Inflammation of aortic wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in transcallosal inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in ankle motor control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in lower limb strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of PhNR_min (photopic negative response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Composition Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Treatment Period Baseline in Log Transformed Urine Albumin Creatinine Ratio (UACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percent Change of FMV UACR From Baseline to Week 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of ovulation inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Classify ovarian activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Aedes aegypti mean number per trap per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Maximum difference between baseline ICP and highest ICP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: General health status (GHQ-12)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Client Satisfaction Questionnaire-4 Scale (CSQ-4)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Primary Care Provider Satisfaction with Psychiatric Care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in parental psychopathology symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in child psychopathology symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in parental emotion regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting 12 Lead ECG QTcF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum Anti COVID-19 antibody (Immunoglobulin G) ratio in Follicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum Anti COVID-19 antibody (Immunoglobulin G) ratio in Spermatic fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Muscle Dysmorphic Disorder Inventory (MDDI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Eating Pathology Symptom Inventory-Clinician Rated Version (EPSI-CRV)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy rate of laminectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes